Connect with us

Insight

The femtech revolution: understanding female hormones and why they matter

By Dr Nicky Keay, Honorary Clinical Lecturer, Division of Medicine, UCL

Published

on

Hormones are key to all aspects of physical and mental health, says Keay

Female hormones are the most complex of all the hormone networks, which partly explains why to date, this is often an unresearched and less well understood area of hormone health.

Fortunately, as a female doctor, I embrace a challenge, especially one so important as female hormone health.

Hormones direct health

Over 2,500 years ago Hippocrates, the father of medicine, advocated for each individual “just the right amount of nourishment and exercise” as “the surest way to health”.

Hippocrates was effectively articulating what we would now call personalised preventative medicine. However, we had to wait over 2,000 years to understand why Hippocrates was right.

The answer lies in the actions of our hormones “setting in motion” the surest way the health. The word hormone is derived from ancient Greek meaning “setting in motion”, reflecting the mechanism of action of a hormone in determining gene expression.

Hormones bring DNA to life by directing which proteins to produce, at what time and how much.

Female hormones

Female hormones orchestrate many aspects of health and well-being, not exclusively reproduction, although that is their evolutionary purpose.

For example, oestradiol – the most active form of oestrogen – is the sex steroid hormone that reigns supreme when it comes to musculoskeletal health.

Low levels of oestradiol are associated with poor bone health, increase risk of fracture and soft tissue injuries. Oestradiol also plays an important role in cardiovascular health. Low levels increase the risk of cardiovascular disease, which is the main cause of death in menopausal women (not breast cancer).

Female ovarian hormones support neurological and cognitive function, together with mood. Low levels of these hormones, in both young and older women, are associated with low mood and “brain fog”.

Harnessing Hormones

As outline by Hippocrates, our lifestyle behaviours play an important part in determining our health. This connection between our behaviours and health is facilitated by hormone networks.

A hormone system often runs according to its own individual biological clock. To harness hormones effectively to optimise health, the trick is to try and harmonise the timing of our behaviours with our internal hormone clocks. However, what happens when the hormone clock in question is very complex and changes over the lifespan?

Female hormone choreography

Out of all the hormone networks, that of the menstrual cycle is the most complex and beautiful.

Each woman will have subtilties of individual timing, levels and biological response relating to this hormone choreography. This is why generic advice is not always helpful or appropriate.

Medical interpretation of female hormone measurements, taken in the clinical context of the individual is essential.

For example, irregular or lack of menstrual periods is an external manifestation that something is amiss with internal hormone choreography. Identifying the most likely cause requires forensic medical interpretation of results, in the clinical context.

For a woman of reproductive age, where regular cyclical variation of hormones would be expected, any disruption of hormone networks, in the absence of medical conditions, could indicate an imbalance in behaviours.

On the other hand, with advancing age, female hormones are expected to wind down in the lead up to menopause when the ovaries retire from their production of eggs and hormones.

Distinguishing between the underlying causes of female hormones dysregulation is essential to be able to direct the individual woman to the most appropriate course of action.

Understanding female hormone choreography

It is inspiring to see the expansion of femtech to provide support for many aspects of female health.

However, when it comes to female hormone choreography over the lifespan, this requires a deep medical understanding of these hormones to unravel the complexities and distinguish between expected biological variation and signs of hormone mistiming.

Artificial Intelligence (AI) techniques are becoming more widespread across many areas of medicine and healthcare.

However, when it comes to female hormones it is more a case of augmented intelligence. Ultimately, even the cleverest mathematical and technological techniques will come to nothing if not directed by medical understanding and interpretation.

On a positive note, appropriately applied, backed by clinical validation and research, these emerging clinical tools will empower women to tune into their personal female hormone choreography and make informed decisions towards the “surest way to health”.

Hormones, Health and Human Potential is out on October 28.

Join one of Dr Nicky Keay’s free discussion events below:

Cambridge

UCL, London

 

Insight

Topical HRT protects bone density in women with period loss – study

Published

on

Transdermal HRT best protects bone density in women with functional hypothalamic amenorrhoea, a condition that stops periods, a review of trials has found.

The meta-analysis pooled randomised clinical trials involving 692 participants and found transdermal hormone replacement therapy and teriparatide increased bone mineral density by between 2 and 13 per cent.

Functional hypothalamic amenorrhoea can follow anorexia or intense exercise. Bone mineral density measures bone strength and the amount of mineral in bone.

Around half of women with the condition have low bone mineral density, compared with about 1 per cent of healthy women, and their fracture risk is up to seven times higher.

The research was conducted by scientists at Imperial College London and Imperial College Healthcare NHS Trust.

Professor Alexander Comninos, senior author of the study and consultant endocrinologist at the trust, said: “Bone density is lost very rapidly in FHA and so addressing bone health early is very important to reduce the lifelong risk of fractures.

“Our study provides much needed comparisons of all the available treatments from all available studies.

“Clearly the best treatment is to restore normal menstrual cycles and therefore oestrogen levels through various psychological, nutritional or exercise interventions – but that is not always possible.

“The foundation for bone health is good calcium and vitamin D intake (through diet and/or supplements) but we have additional treatments that are more effective.”

When FHA is diagnosed, clinicians first try to restore periods through lifestyle measures, including psychological and dietary support, but these can fail. Guidelines then recommend giving oestrogen, though the best form was unclear.

The team reviewed all prior randomised trials comparing therapies, including oral and transdermal oestrogen, and also assessed teriparatide, a prescription bone-building drug used for severe osteoporosis.

They found no significant benefit for oral contraceptive pills or oral hormone therapy.

A recent UK audit reported that about a quarter of women with anorexia-related FHA are prescribed the oral contraceptive pill for bone loss; the study suggests using transdermal therapy instead.

Comninos said: “Our goal is simple: to help women receive the right treatment sooner and to protect their bone health in the long-term.

“We hope this study provides clinicians with better evidence to choose transdermal oestrogen when prescribing oestrogen and so inform future practice guidelines.

“Right now, millions of women with FHA may not be receiving the best treatments for their bone health.”

Continue Reading

Insight

AI cuts interval breast cancers in Swedish trial

Published

on

An AI tool cut interval breast cancers by 12 per cent in a Swedish screening trial of more than 105,000 women.

The study also found 27 per cent fewer aggressive breast cancers detected at screening when AI was used.

Interval cancers are cancers found between routine screening appointments because they were missed at the original scan. They are often more dangerous and linked to higher death rates than cancers found at screening.

The MASAI trial is described as the first large randomised study to test whether AI can improve mammography screening, which uses low-dose X-rays to examine breast tissue for signs of cancer.

The AI tool, called Transpara Detection and developed by ScreenPoint Medical, supported radiologists in analysing mammography images.

Earlier results from the same trial showed that Transpara Detection increased cancers found by 29 per cent and reduced radiologist workload by 44 per cent compared with standard double-reading, where two radiologists independently review each scan.

The latest findings indicate higher accuracy with AI support. Sensitivity, the ability to detect cancer, was 6.7 percentage points higher in the AI group while specificity, the ability to rule out healthy cases, was maintained. Results were similar across age groups and breast density levels.

Women screened with AI had 16 per cent fewer invasive interval cancers and 21 per cent fewer large interval cancers than those in the standard screening group.

The system also helps doctors assess risk more precisely by subdividing suspicious findings into BI-RADS 4 categories A, B and C. BI-RADS (Breast Imaging Reporting and Data System) is a standardised scale that guides whether a patient needs closer monitoring, further tests or treatment.

Continue Reading

Wellness

WUKA and Royal Yachting Association partner to support women and girls in sailing

Published

on

WUKA has announced a groundbreaking partnership with the Royal Yachting Association (RYA), including RYA Scotland and RYA Northern Ireland, supporting women and girls in sailing.

Building on WUKA’s growing #TackleAnything campaign – which has already reached thousands of girls across sports in the UK – this collaboration brings practical period solutions into sailing.

Together, WUKA and the RYA are committed to breaking down barriers so periods never limit confidence, participation, or performance on the water.

Ruby Raut, WUKA founder & CEO, said: “Partnering with the RYA has been incredibly important for us at WUKA.

“Sailing is an amazing way for women and girls to build confidence, and periods shouldn’t hold anyone back from enjoying the water or reaching their full potential.

“Through this partnership and our #TackleAnything campaign, we’re proud to provide practical solutions and innovative products that help female sailors feel comfortable, confident, and free to focus on learning, performing, and having fun.

“Breaking down barriers and supporting women to tackle anything — on land, at sea, and everywhere in between – has never felt more meaningful.”

WUKA, which stands for Wake-Up Kick Ass, shares the RYA’s commitment to inclusivity and empowerment.

In 2023, WUKA launched #TackleAnything, a campaign supporting women, girls and sportspeople with periods. Since its launch, the initiative has reached 3,576 girls across 46 clubs and partnered with a range of sports across the UK – from Scottish Gymnastics to Titans wheelchair basketball – helping young athletes play without limits and stay confident, comfortable, and in the game.

The brand offers period-friendly aquatic apparel and practical solutions that help women train and compete with freedom of movement and total assurance.

Through this partnership, WUKA will provide innovative period swimwear for young sailors across key RYA programmes, including the NI Sailing Team, the RYA Scotland Performance Pathway Programme, and the British Sailing Pathways Talent Academies.

By combining WUKA’s mission to challenge stigma with the RYA’s commitment to inclusion, the partnership ensures young sailors can focus on what matters most – learning, performing, and enjoying their time on the water – with confidence and comfort. RYA members will also receive a 10 per cent discount on WUKA products.

Sailing offers incredible benefits for women and girls, but time on the water can present unique challenges -particularly during menstruation.

Together, WUKA and the RYA are providing practical solutions that remove these barriers, helping young sailors participate fully and confidently in the sport.

Sara Sutcliffe, RYA CEO, said: “At the RYA, we have been making strides to break down barriers for women of all ages to help ensure they can experience the water in a supportive and positive environment.

“From education workshops and practical sessions, we want to make sure our female sailors are empowered and this partnership is another great example of how we can demonstrate possible tools to equip them to succeed”.

This partnership is part of the RYA’s wider commitment to making sailing a sport where women and girls can thrive. Alongside initiatives such as the Female Futures Group, the Women’s Race Officials Programme and all new Talent Academy Female Future’s Camps; it demonstrates a continued focus on removing barriers and creating meaningful opportunities across every stage of the sailing.

WUKA’s involvement ensures that practical solutions are available on the water, from innovative period swimwear to support resources, helping young sailors feel fully equipped and confident during training and competition.

By integrating these tools into RYA programmes, WUKA brings a new level of comfort and assurance to female athletes, allowing them to focus entirely on performance, enjoyment, and growth in the sport.

For any women and girls looking to learn more about sailing, visit www.rya.org.uk.

For more information on WUKA visit www.wuka.co.uk.

Continue Reading

Trending

Copyright © 2025 Aspect Health Media Ltd. All Rights Reserved.